Yahoo
Stockholm - Delayed Quote SEK

Paxman AB (publ) (PAX.ST)

63.30 -0.50 (-0.78%)
At close: 5:09:37 PM GMT+1
Chart Range Bar
Loading chart for PAX.ST
  • Previous Close 63.80
  • Open 64.60
  • Bid 63.20 x --
  • Ask 63.30 x --
  • Day's Range 63.00 - 64.90
  • 52 Week Range 41.00 - 69.90
  • Volume 12,234
  • Avg. Volume 26,418
  • Market Cap (intraday) 1.473B
  • Beta (5Y Monthly) 0.51
  • PE Ratio (TTM) --
  • EPS (TTM) -0.22
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 96.00

Paxman AB (publ), together with its subsidiaries, provides cryotherapy solutions in the United Kingdom, Europe, North and South America, Oceania, and Asia. The company offers Paxman scalp cooling system, a mechanized form of scalp cooling for the prevention of chemotherapy-induced alopecia. It also engages in the development of a medical cryocompression device for the prevention of chemotherapy-induced peripheral neuropathy. The company was founded in 1996 and is based in Karlshamn, Sweden.

paxmanscalpcooling.com

151

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

PAX.ST
12.63%
OMX Stockholm 30 Index (^OMX)
13.93%

1-Year Return

PAX.ST
6.08%
OMX Stockholm 30 Index (^OMX)
19.20%

3-Year Return

PAX.ST
132.72%
OMX Stockholm 30 Index (^OMX)
54.43%

5-Year Return

PAX.ST
2.43%
OMX Stockholm 30 Index (^OMX)
41.71%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 105M
Earnings 2.56M
Profit Margin 2.44%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
20M
40M
60M
80M
100M
-10.0%
-5.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

89.00
96.00 Average
63.30 Current
103.00 High

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.54%

  • Return on Assets (ttm)

    0.19%

  • Return on Equity (ttm)

    -1.30%

  • Revenue (ttm)

    365.91M

  • Net Income Avi to Common (ttm)

    -5.64M

  • Diluted EPS (ttm)

    -0.22

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    105.64M

  • Total Debt/Equity (mrq)

    2.97%

  • Levered Free Cash Flow (ttm)

    -31.72M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: